Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of a Radiomics Signature for Clinically Significant Portal Hypertension in Cirrhosis (CHESS1701): a Prospective Multicenter Study

NCT03138915 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT03138915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03138915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of a Radiomics Signature for Clinically Significant Portal Hypertension in Cirrhosis (CHESS1701): a Prospective Multicenter Study
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Not applicable
Overall status
Completed
Start date
May 18, 2017
Completion date
October 8, 2017
Enrollment
385 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, portal